Article ID Journal Published Year Pages File Type
6120983 Journal of Clinical Virology 2013 6 Pages PDF
Abstract
Rituximab therapy may increase the risk of developing HBV-R in NHL patients with HBcAb(+).
Keywords
Related Topics
Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology
Preview
Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis
Authors
, , , , , ,